Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Siemens AG. (12/15/17). "Press Release: Siemens Healthineers Announces Acquisition of Fast Track Diagnostics". Erlangen.

Organisations Organisation Siemens Healthcare GmbH (Siemens Healthineers)
  Group Siemens (Group)
  Organisation 2 Fast Track Diagnostics Luxembourg S.à.r.l.
  Group Siemens (Group)
Products Product molecular diagnostics
  Product 2 healthcare
Index terms Index term Fast Track Diagnostics–Siemens: investment, 201712 acquisiton €na of FTD by Siemens Healthineers
  Index term 2 NEO New Oncology–Siemens: investment, 201603 acquisiton by Siemens Healthcare GmbH
Persons Person Beils, Fernando (Siemens 201712 Head of Molecular Diagnostics at Siemens Healthineers)
  Person 2 Carman, Bill (Fast Track Diagnostics 201712 CEO)

> Acquisition underlines the importance for Siemens Healthineers to invest in the growing market of molecular testing

> With the expansion of its portfolio by Fast Track Diagnostics' molecular diagnostic tests, Siemens Healthineers offers its customers solutions that reduce time in the lab for detection of infections while improving patient outcomes

Siemens Healthineers has signed an agreement to acquire Luxembourg-based Fast Track Diagnostics (FTD), a global supplier of molecular diagnostic tests. The acquisition of FTD underscores the Siemens Healthineers commitment to molecular diagnostics, a designated growth area for the company. Through the acquisition, Siemens Healthineers will now include FTD's sites in Luxembourg, Malta, and India, as well as its workforce of about 80 employees. FTD will continue to operate under the brand name Fast Track Diagnostics throughout the world. The closing of the acquisition is targeted by the end of the year 2017. Terms of the agreement were not disclosed.

Over the past 24 months, Siemens Healthineers has made significant advancements in the delivery of molecular diagnostic applications and services, such as the acquisition of NEO New Oncology last year. By introducing FTD products to its molecular diagnostics portfolio, the company is further investing in precision medicine and better patient experience. The tests target conditions such as respiratory infections, gastroenteritis, meningitis, hepatitis, infections of the immunosuppressed, tropical diseases, sexually transmitted diseases, and early childhood diseases, and can detect over 140 viruses, bacteria, parasites, and fungi.

"By integrating the high-quality and cost effective solutions of Fast Track Diagnostics into our own cutting-edge molecular diagnostics portfolio, Siemens Healthineers continues to strengthen and expand its presence in the field of molecular testing and precision medicine," says Fernando Beils, Head of Molecular Diagnostics, Siemens Healthineers. "We are excited to introduce the world-class team to the Siemens Healthineers family."

"Combining FTD's wide range of assays with the Siemens Healthineers portfolio means great things for all of our customers globally," says Bill Carman, CEO of Fast Track Diagnostics. "In merging our efforts, we're enabling healthcare providers to meet their current challenges and deliver better outcomes for patients."

More information about Fast Track Diagnostics is available at

The products/features mentioned herein are not commercially available in all countries. Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability. Please contact your local Siemens Healthineers organization for further details.

Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to achieve better outcomes at lower costs by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.8 billion and profit of €2.5 billion and has about 48,000 employees worldwide. Further information is available at

Reference Number: PR2017120116HCEN

Link to this Press Release


Fast Track Diagnostic

Website: Siemens Healthineers


Mr. Thorsten Opderbeck
Siemens Healthcare GmbH
Henkestr. 127
91052 Erlangen
Tel: +49 (9131) 84-4906

Record changed: 2017-12-22


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Siemens (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top